Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

SEI: Alternatives go mainstream

Wednesday, June 12, 2013

Benedicte Gravrand, Opalesque Geneva: - The market opportunity for retail alternatives is already huge, continues to grow, yet is still in its infancy, says SEI in a new 24-page report called "The Retail Alternatives Phenomenon."

SEI is a leading global provider of investment processing, fund processing and investment management business outsourcing solutions, with headquarters in the U.S. and offices throughout the world.

Within institutional investing, the report says, the move toward alternatives has been a tremendous development, which saw two waves of rapid growth in the past decade: between 2005 an 2007, when global alternative asset classes’ assets under management (AuM) went from $2.9tln to $5.7tln; and post-2008, when AuM reached $6.5tln by the end of 2011, outpacing the AuM growth of traditional asset classes. The third wave of growth in alternative investing is underway, SEI states, only this time it is encompassing the mainstream, as alternatives are moving from institutional to retails markets.

Indeed, alternative strategies that are normally used by hedge funds and private equity are increasingly being packaged as mutual funds in the U.S. and as UCITS in Europe. This is what SEI's well-written report calls "retail alternatives."

"Based on the recent growth of hedge-style mutual funds, the blend of alternative strategies with the transparency, liquidity and regulatory oversight of regulated retail investment vehicles has gr......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner